Sign inJoin waitlistJoin the waitlist

Jochen Lorch

Professor, Medicine · McGaw Medical Center of Northwestern University

Credentials: · · · ·

History

McGaw Medical Center of Northwestern University
Present

McGaw Medical Center of Northwestern University
2000–2002
University of Pennsylvania Health System
1996–1999
Universität Regensburg Fakultät für Medizin
1990–1994

Research

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
The Lancet Oncology · 2016 · 955 citations
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
New England Journal of Medicine · 2020 · 631 citations
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
Cancer Discovery · 2018 · 630 citations

Robert Haddad
50 papers
GH
Glenn Hanna
30 papers · 7 as a resident
Roy Tishler
28 papers
Jonathan Schoenfeld
23 papers
NC
Nicole Chau
22 papers
Danielle Margalit
20 papers
Justine Barletta
20 papers
MP
Marshall Posner
18 papers
GR
Guilherme Rabinowits
17 papers
Laura Goguen
17 papers
Donald Annino
14 papers
Matthew Nehs
12 papers

Clinical trials

Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Principal investigator · Recruiting · Phase 2
Northwestern University
2025–2035
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Principal investigator · Recruiting · Phase 2
Jochen Lorch
2025–2030
Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer
Principal investigator · Suspended · Phase 2
Northwestern University
2022–2030
RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer
Principal investigator · Terminated · Phase 1
Dana-Farber Cancer Institute
2010